Index RUT P/E - EPS (ttm) -3.20 Insider Own 17.31% Shs Outstand 20.15M Perf Week 8.23%
Market Cap 363.65M Forward P/E 18.52 EPS next Y 1.06 Insider Trans -0.70% Shs Float 16.66M Perf Month 0.00%
Enterprise Value 328.52M PEG 8.34 EPS next Q 0.29 Inst Own 89.42% Short Float 6.90% Perf Quarter 24.76%
Income -64.25M P/S 4.62 EPS this Y -0.55% Inst Trans -8.42% Short Ratio 3.00 Perf Half Y 15.57%
Sales 78.68M P/B 3.11 EPS next Y 3.35% ROA -38.39% Short Interest 1.15M Perf YTD 7.52%
Book/sh 6.31 P/C 10.19 EPS next 5Y 2.22% ROE -41.21% 52W High 37.67 -47.96% Perf Year -35.51%
Cash/sh 1.92 P/FCF 15.80 EPS past 3/5Y - - ROIC -50.39% 52W Low 12.39 58.19% Perf 3Y -47.91%
Dividend Est. - EV/EBITDA 22.73 Sales past 3/5Y 13.67% 13.74% Gross Margin 59.60% Volatility 9.16% 4.89% Perf 5Y -73.89%
Dividend TTM - EV/Sales 4.18 EPS Y/Y TTM -877.37% Oper. Margin 9.12% ATR (14) 1.01 Perf 10Y 97.78%
Dividend Ex-Date Jul 29, 2024 Quick Ratio 5.62 Sales Y/Y TTM 5.69% Profit Margin -81.66% RSI (14) 57.95 Recom 2.14
Dividend Gr. 3/5Y - - Current Ratio 5.62 EPS Q/Q 227.45% SMA20 3.83% Beta 1.12 Target Price 23.33
Payout - Debt/Eq 0.00 Sales Q/Q -2.66% SMA50 7.64% Rel Volume 2.38 Prev Close 18.05
Employees 213 LT Debt/Eq 0.00 Earnings Jan 08 AMC SMA200 -2.06% Avg Volume 383.54K Price 19.60
IPO Jun 18, 1997 Option/Short Yes / Yes EPS/Sales Surpr. -34.04% 1.99% Trades
Volume 914,448 Change 8.59%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-18-25 Downgrade BTIG Research
Buy → Neutral
Sep-30-25 Initiated TD Cowen
Hold
$16
Jul-15-25 Downgrade KeyBanc Capital Markets
Overweight → Sector Weight
Nov-15-24 Initiated Stephens
Overweight
$39
Jul-29-24 Initiated KeyBanc Capital Markets
Overweight
$47
Jul-16-24 Initiated JMP Securities
Mkt Perform
Jun-28-24 Initiated William Blair
Outperform
May-09-23 Initiated BTIG Research
Buy
$55
Oct-26-21 Upgrade Craig Hallum
Hold → Buy
$65 → $53
Jan-12-21 Downgrade Craig Hallum
Buy → Hold
Oct-16-20 Initiated Raymond James
Outperform
$95
Sep-08-20 Initiated Oppenheimer
Outperform
$79
Jan-06-20 Initiated Craig Hallum
Buy
$40
Show Previous Ratings
Jan-09-26 07:25AM
12:00AM
Jan-08-26 06:05PM
04:14PM
(Associated Press Finance)
04:05PM
09:39AM
Loading…
09:39AM
Dec-22-25 09:53AM
Dec-18-25 12:00PM
07:50AM
Dec-17-25 07:50AM
Dec-09-25 08:35AM
07:55AM
Dec-04-25 12:50PM
08:56AM
Dec-02-25 03:40PM
09:06AM
Loading…
09:06AM
12:00AM
Dec-01-25 04:32PM
(Associated Press Finance)
04:05PM
Nov-28-25 07:16AM
Nov-26-25 09:49AM
Nov-24-25 10:00AM
Nov-14-25 09:55AM
Nov-06-25 08:20PM
Nov-05-25 12:37PM
12:13PM
11:57AM
11:51AM
10:27AM
Nov-04-25 01:46PM
12:50PM
Loading…
Nov-03-25 12:50PM
12:43PM
12:10PM
Oct-31-25 12:53PM
Oct-29-25 10:00AM
09:55AM
08:46AM
05:45AM
Oct-22-25 07:50AM
Oct-20-25 09:38AM
Oct-07-25 05:30AM
Sep-05-25 06:34PM
Aug-27-25 07:50AM
Aug-11-25 03:21PM
Aug-01-25 10:39AM
10:34AM
Jul-31-25 10:56AM
10:30AM
Jul-30-25 09:54AM
Jul-29-25 08:52AM
07:50AM
Jul-28-25 08:20AM
Jul-25-25 09:18AM
Jul-24-25 10:59AM
Jul-23-25 10:22AM
10:15AM
09:52AM
Jul-19-25 02:38AM
Jul-15-25 01:56PM
09:17AM
03:02AM
Jul-14-25 04:15PM
04:13PM
(Associated Press Finance)
04:05PM
Jul-07-25 10:00AM
Jun-18-25 04:05PM
Jun-17-25 07:58AM
Jun-14-25 08:45AM
Jun-12-25 10:18AM
07:50AM
Jun-11-25 04:30PM
Jun-05-25 05:20PM
07:50AM
Jun-03-25 10:30AM
May-21-25 10:02AM
May-19-25 08:26AM
May-15-25 07:50AM
May-02-25 09:40AM
May-01-25 09:44AM
09:38AM
Apr-29-25 08:48AM
Apr-23-25 10:24AM
07:27AM
06:01AM
Apr-21-25 07:50AM
05:42AM
Apr-16-25 08:30AM
Apr-04-25 11:24AM
08:44AM
08:02AM
(Thomson Reuters StreetEvents)
03:01AM
Apr-03-25 08:44PM
05:20PM
04:17PM
(Associated Press Finance)
04:05PM
Apr-01-25 09:04AM
Mar-20-25 07:00AM
Mar-10-25 07:00AM
Feb-04-25 07:30AM
Jan-22-25 07:50AM
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LaVange Lisa Director Dec 01 '25 Sale 16.91 866 14,644 9,968 Dec 02 04:14 PM LISA LAVANGE Director Dec 01 '25 Proposed Sale 17.00 866 14,722 Dec 01 04:35 PM WOLTOSZ WALTER S Director Oct 01 '25 Sale 15.39 20,000 307,800 3,286,231 Oct 03 04:13 PM VIRGINIA EVANS WOLTOSZ & WALTE Director Oct 01 '25 Proposed Sale 15.07 20,000 301,400 Oct 01 04:29 PM LaVange Lisa Director Sep 02 '25 Sale 14.10 867 12,225 9,063 Sep 04 04:18 PM LaVange Lisa Director Aug 01 '25 Sale 12.93 867 11,210 9,930 Aug 04 04:21 PM LISA LAVANGE Director Aug 01 '25 Proposed Sale 13.02 1,734 22,577 Aug 01 04:29 PM WOLTOSZ WALTER S Director Jul 01 '25 Sale 18.33 20,000 366,623 3,304,157 Jul 02 04:24 PM VIRGINIA EVANS WOLTOSZ & WALTE Director Jul 01 '25 Proposed Sale 17.45 60,000 1,047,000 Jul 01 04:34 PM WOLTOSZ WALTER S Director Jun 02 '25 Sale 27.15 20,000 543,074 3,324,157 Jun 03 04:57 PM WOLTOSZ WALTER S Director May 01 '25 Sale 33.51 20,000 670,150 3,344,157 May 01 05:53 PM WOLTOSZ WALTER S Director Apr 01 '25 Sale 24.09 20,000 481,786 3,363,371 Apr 02 04:20 PM VIRGINIA EVANS WOLTOSZ & WALTE Director Apr 01 '25 Proposed Sale 24.52 60,000 1,471,200 Apr 01 04:20 PM WOLTOSZ WALTER S Director Mar 03 '25 Sale 28.68 20,000 573,600 3,383,371 Mar 04 05:08 PM WOLTOSZ WALTER S Director Feb 03 '25 Sale 33.91 20,000 678,243 3,402,584 Feb 04 05:33 PM
